News Industry News Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy July 20, 2022
News Daily News INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease Michael O'Riordan July 12, 2022
News Daily News Postop AF Portends Higher Risk of HF Hospitalization in the Next Few Years Caitlin E. Cox June 30, 2022
News Conference News ACC 2022 Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years Michael O'Riordan April 04, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Daily News Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis Yael L. Maxwell March 09, 2022
News Daily News Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience Caitlin E. Cox March 08, 2022
News Conference News STS 2022 Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database L.A. McKeown February 02, 2022
News Conference News AHA 2021 Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years Caitlin E. Cox November 13, 2021
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News TCT 2021 SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years Todd Neale November 05, 2021
News Daily News Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs Michael O'Riordan October 01, 2021
News Daily News TAVI Is Broadening the Treatable AS Population, Not Cutting Into SAVR Todd Neale September 30, 2021
News Daily News EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management L.A. McKeown September 22, 2021